Type I conventional dendritic cells and CD8<sup>+</sup> T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients.

导出 LinkOut

翻译打印收藏纠错

作者： Johanna,Kirchner ^[1] ; Ioana,Plesca ^[2] ; Rebecca,Rothe ^[3] ; Antonia,Resag ^[3] ; Steffen,Löck ^[4] ; Iva,Benešová ^[3] ; Luise,Rupp ^[1] ; Annett,Linge ^[2] ; Rebekka,Wehner ^[4] ; Mechthild,Krause ^[5] ; Marc,Schmitz ^[3]

作者单位： OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany. ^[1] Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. ^[2] Faculty of Medicine Carl Gustav Carus, Institute of Immunology, Technische Universität Dresden, Dresden, Germany. ^[3] National Center for Tumor Diseases (NCT), Partner Site Dresden; German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[4] German Cancer Consortium (DKTK), partner site Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany. ^[5] Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiooncology - OncoRay, Dresden, Germany. ^[6]

关键词 T cells dendritic cells head and neck squamous cell carcinoma human papilloma virus hypoxia multiplex imaging spatial biology tumor microenvironment